ŠLAIS, Karel, Leoš LANDA and Alexandra ŠULCOVÁ. The effects of cannabinoid CB1 receptor antagonist AM 251 on locomotor/exploratory behaviour and body weight in mice. European Neuropsychopharmacology. Amsterdam: Elsevier, 2003, vol. 13, Suppl. 4, p. 417 - 417. ISSN 0924-977X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The effects of cannabinoid CB1 receptor antagonist AM 251 on locomotor/exploratory behaviour and body weight in mice
Authors ŠLAIS, Karel (203 Czech Republic), Leoš LANDA (203 Czech Republic) and Alexandra ŠULCOVÁ (203 Czech Republic, guarantor).
Edition European Neuropsychopharmacology, Amsterdam, Elsevier, 2003, 0924-977X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.842
RIV identification code RIV/00216224:14110/03:00008971
Organization unit Faculty of Medicine
UT WoS 000185412300678
Keywords in English body weight; AM 251; locomotor/exploratory behaviour; mice
Tags AM 251, body weight, locomotor/exploratory behaviour, mice
Tags International impact
Changed by Changed by: MUDr. Mgr. Karel Šlais, Ph.D., učo 19989. Changed: 24/6/2009 13:26.
Abstract
The effects of the cannabinoid CB1 receptor antagonist AM 251 were assessed in adult, non-obese male mice. The changes in the behaviour recorded were aimed on locomotor/exploratory activity of mice in the open field test. The daily administration of AM 251 reduced dose-dependently and significantly body weight, while did not significantly affect locomotor/exploratpry activities neither after acute nor repeated administration.
PrintDisplayed: 10/9/2024 13:14